Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.69M Sell
51,100
-83,600
-62% -$9.89M 0.01% 1202
2025
Q4
$18.2M Buy
+134,700
New +$14.7M 0.03% 602

Other funds holding ABVX

Group One Trading's ABVX Position: Q1 2026 in Review

Group One Trading increased its Abivax (ABVX) stake by 106% in Q1 2026, buying an estimated $2.18M and bringing the position to 35,767 shares worth $3.98M. The position accounts for 0.01% of the portfolio, ranked #1482.

Group One Trading first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Group One Trading held 35,767 shares of Abivax worth $3.98M as of Q1 2026.
  • Group One Trading bought 18,384 Abivax shares in Q1 2026, an estimated $2.18M.
  • Abivax made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1482 holding.
  • Group One Trading first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.